Case 3. Bortezomib in primary refractory plasmacytoma

被引:7
作者
Chim, CS [1 ]
Ooi, GC
Loong, F
An, AWM
Lie, AW
机构
[1] Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Univ Dept Radiol, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Queen Mary Hosp, Univ Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1200/JCO.2005.04.079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2426 / 2428
页数:3
相关论文
共 8 条
[1]  
Alexiou C, 1999, CANCER, V85, P2305, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.3.CO
[2]  
2-V
[3]   Unusual presentations of hematologic malignancies - CASE 1. Solitary bone plasmacytoma: Role of magnetic resonance Imaging and positron emission tomography [J].
Chim, CS ;
Ooi, GC ;
Loong, F ;
Liang, R .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1328-1330
[4]  
Durie BGM, 2002, J NUCL MED, V43, P1457
[5]   Management of multiple myeloma: a systematic review and critical appraisal of published studies [J].
Kumar, A ;
Loughran, T ;
Alsina, M ;
Durie, BGM ;
Djulbegovic, B .
LANCET ONCOLOGY, 2003, 4 (05) :293-304
[6]   Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells:: therapeutic implications [J].
Mitsiades, CS ;
Mitsiades, N ;
Poulaki, V ;
Schlossman, R ;
Akiyama, M ;
Chauhan, D ;
Hideshima, T ;
Treon, SP ;
Munshi, NC ;
Richardson, PG ;
Anderson, KC .
ONCOGENE, 2002, 21 (37) :5673-5683
[7]   A phase 2 study of bortezomib in relapsed, refractory myeloma [J].
Richardson, PG ;
Barlogie, B ;
Berenson, J ;
Singhal, S ;
Jagannath, S ;
Irwin, D ;
Rajkumar, SV ;
Srkalovic, G ;
Alsina, M ;
Alexanian, R ;
Siegel, D ;
Orlowski, RZ ;
Kuter, D ;
Limentani, SA ;
Lee, S ;
Hideshima, T ;
Esseltine, DL ;
Kauffman, M ;
Adams, J ;
Schenkein, DP ;
Anderson, KC .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617
[8]  
Salmon Sydney E., 1997, P2344